Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep829 | Pituitary: clinical | ECE2015

Glucose homeostasis alterations in Cushing's disease: epidemiology, anthropometric assessment and the role of family history of type 2 diabetes

Witek Przemyslaw , Witek Joanna , Zielinski Grzegorz , Blazik Marlena , Kaminski Grzegorz

Introduction: Cushing’s disease (CD) leads to glucose homeostasis alterations, obesity, unfavorable changes in body composition and cardiovascular complications.Aim of study: i) Prospective evaluation of the frequency of pre-diabetes and diabetes. ii) Assessment of insulin resistance (IR) indices in CD. iii) Analysis of the influence of family history of type 2 diabetes (T2D) on the anthropometry in CD.Methods: The study group...

ea0037ep830 | Pituitary: clinical | ECE2015

Cushing's disease: reversibility of glucose homeostasis alterations and improvement in insulin resistance indices following a successful, transsphenoidal surgery

Witek Joanna , Witek Przemyslaw , Zielinski Grzegorz , Blazik Marlena , Kaminski Grzegorz

Introduction: Cortisol excess in Cushing’s disease (CD) leads to glucose homeostasis alterations and increased cardiovascular risk.Aim of the study: i) To assess the reversibility of glucose homeostasis alterations and dynamics of inflammatory and coagulation parameters after the successful transsphenoidal surgery (TSS) for CD. ii) Analysis of the early improvement in insulin resistance (IR) indices following TSS.Methods: The ...

ea0037ep1092 | Endocrine tumours | ECE2015

Analysis of current indications to bilateral adrenalectomy

Kurowska Maria , Malicka Joanna , Zwolak Agnieszka , Tarach Jerzy S

Introduction: Bilateral adrenalectomy (BA) is rarely applied as a therapeutic procedure. It serves as a life-saving treatment in patients with persistent Cushing’s disease after an ineffective pituitary surgery or in ectopic ACTH production. Other indications for BA are: bilateral adrenocortical adenomas, congenital adrenal hyperplasia and bilateral phaeochromocytoma in patients with hereditary paraganglioma-phaeochromocytoma (PPS/PGL) syndromes. It is also a procedure of...

ea0037ep1153 | Clinical Cases–Pituitary/Adrenal | ECE2015

Recurrent hyponatremia in woman with undiagnosed postpartum pituitary insufficiency

Kurowska Maria , Malicka Joanna , Zwolak Agnieszka , Tarach Jerzy S

Introduction: Hyponatremia occurs in 33–69% of women with postpartum pituitary necrosis. The aim of the study was to present a patient in whom recurrent hyponatremia was one of the dominant symptoms of postpartum anterior pituitary hormones deficiency.A case report: 55-year-old woman with a diagnosis of Sheehan syndrome established 19 years after the last labor complicated by massive bleeding due to uterine atonia. The first symptoms of pituitary in...

ea0036P51 | (1) | BSPED2014

What is the optimum cardiovascular screening in Turner syndrome during childhood and adolescence? Is it achievable?

Turtle Emma , Laycock Joanna , Roach Jennifer , Bath Louise

Introduction: Women with Turner syndrome (TS) have a 13-year reduction in life expectancy compared to the general population. Cardiovascular disease (CVD), whether congenital or acquired, is the cause of death in around half of these women. Therefore, early identification of congenital heart defects, aortic abnormalities and risk factors for CVD is extremely important, and may have a significant impact on long-term outcomes of CVD in TS.Aim and methods: ...

ea0035p222 | Clinical case reports Pituitary/Adrenal | ECE2014

Hyponatremia as a first symptom of hypopituitarism in an adult patient with natural history of craniopharyngioma undiagnosed since childhood

Witek Przemyslaw , Kaminski Grzegorz , Witek Joanna , Zielinski Grzegorz

Background: Craniopharyngiomas may lead to pituitary insufficiency and neurological symptoms. However the rate of the tumor growth and the time of developing hypopituitarism are difficult to predict.Case report: A 68-year-old male of short stature (height 148 cm) was admitted to the area hospital due to loss of consciousness. The acute coronary syndrome and stroke had been excluded but laboratory tests showed hyponatremia of 106 mmol/l. Hormone measureme...

ea0035p294 | Clinical case reports Thyroid/Others | ECE2014

Brown tumors: the first and the final manifestation of primary hyperparathyroidism.

Sztembis Joanna , Orlowska-Florek Renata , Dryja Agata , Swider Grzegorz

Introduction: Brown tumor–well circumscribed lytic lesion is one of the complication of advanced stage of primary and secondary hyperparathyroidism. It may be also a first clinical sign of primary hyperparathyroidism. Nowadays this is rare manifestation in developed countries due to increased use of routine screening laboratory examinations. Brown tumors may also mimic true neoplasm and lead to misdiagnosis if close attention is not paid. We present three case reports and...

ea0035p556 | Endocrine tumours and neoplasia | ECE2014

Catecholamin crisis as a first manifestation of multiple endocrine neoplasia type 2A

Zwolak Agnieszka , Rudzki Grzegorz , Swirska Joanna , Tarach Jerzy

Introduction: Multiple endocrine neoplasia type 2A (MEN2A) is a multi-glandular autosomal dominant genetic disorder which, most typically, includes medullary carcinoma of the thyroid, pheochromocytoma and primary hyperparathyroidism. The authors present a case study of a young man in whom cardiogenic shock was the first manifestation of pheochromocytoma and MEN2A.Case report: A 30-year-old man without a past history of hypertension or any other chronic m...

ea0035p793 | Paediatric endocrinology | ECE2014

Effectiveness of GH therapy in children with normal results of GH stimulation tests and with partial GH deficiency is similar and depends on the severity of IGF1I deficiency

Smyczynska Joanna , Stawerska Renata , Lewinski Andrzej , Hilczer Maciej

Introduction: GH therapy in children with normal GH peak in stimulation tests (GHST) is still a matter of discussion. Recently, GH deficiency (GHD) has been defined as secondary IGF1 deficiency (IGFD), however GHST still remain the main procedure in diagnosing GHD.The aim of present study was to compare GH therapy effectiveness in the patients with normal results of GHST (normGH) and with isolated partial GHD (pGHD), with respect to IGF-I secretion befor...

ea0035p836 | Pituitary Basic (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Survivin expression in invasive pituitary gland adenomas with a diameter exceeding 20 mm

Waligorska-Stachura Joanna , Sawicka-Gutaj Nadia , Andrusiewicz Miroslaw , Ruchala Marek

Introduction: Survivin is a multifunctional protein and acts as an inhibitor of apoptosis. Its expression occurs in nearly all human cancers. In some tumors survivin expression correlates with the malignant behavior and diminished response to cytotoxic therapy. Data concerning survivin expression in invasive pituitary gland adenomas are contradictory.Patients and methods: Survivin expression was assessed in 38 invasive pituitary gland adenomas (31 non-fu...